The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: methylprednisolone     Quarter: 2016Q3

Total Records: 857     Number of Pages: 43

DRUGNAME PT EventCount
METHYLPREDNISOLONE. Fall 2
METHYLPREDNISOLONE. Feeling abnormal 2
METHYLPREDNISOLONE. Feeling hot 2
METHYLPREDNISOLONE. Generalised tonic-clonic seizure 2
METHYLPREDNISOLONE. Glomerulonephritis proliferative 2
METHYLPREDNISOLONE. Granulocytopenia 2
METHYLPREDNISOLONE. Hemiparesis 2
METHYLPREDNISOLONE. Hepatitis B 2
METHYLPREDNISOLONE. Hyperuricaemia 2
METHYLPREDNISOLONE. Hypoxia 2
METHYLPREDNISOLONE. Immunosuppressant drug level increased 2
METHYLPREDNISOLONE. Infection reactivation 2
METHYLPREDNISOLONE. Infusion related reaction 2
METHYLPREDNISOLONE. Invasive ductal breast carcinoma 2
METHYLPREDNISOLONE. Joint swelling 2
METHYLPREDNISOLONE. Lactic acidosis 2
METHYLPREDNISOLONE. Large intestine perforation 2
METHYLPREDNISOLONE. Leukocytosis 2
METHYLPREDNISOLONE. Leukopenia 2
METHYLPREDNISOLONE. Liver disorder 2

Total Records: 857     Number of Pages: 43